文献速递脑血管病

PETS-Stroke 验证与可行性:卒中后治疗负担的患者报告测量工具

Validation and Feasibility of PETS-Stroke: A Patient-Reported Measure of Treatment Burden After Stroke.
PubMed 文献 · Stroke · 2025-05-29

结果显示 9 因子结构拟合最佳,内部一致性良好(Omega 0.729–0.921),各领域重测信度 ICC>0.7,缺失数据在 7 个领域可接受。结论认为 PETS-Stroke 是有效且可行的卒中后治疗负担测量工具。

要点

  • PETS-Stroke 为卒中特异性治疗负担患者报告量表,改编自 PETS v2.0。
  • 9 因子结构拟合最佳,Omega 0.729–0.921,各领域重测信度 ICC>0.7。
  • 缺失数据在 7 个领域处于可接受范围,定性反馈认为问卷易于快速完成。

核心结论

  • 心理测量性能提示 PETS-Stroke 是有效且可行的卒中后治疗负担测量工具。

主要发现

  • 验证性因子分析显示 9 因子结构拟合最佳,内部一致性良好(Omega 值 0.729–0.921)。
  • 9 个领域中 8 个领域的各指标条目因子负荷为中至强。
  • PETS-Stroke 所有领域与至少一种其他患者报告测量呈中至强相关。
  • 所有领域重测信度良好(组内相关系数 >0.7)。
  • PETS-Stroke 评分在 3 个领域因多病共存显著不同,在 8 个领域因社会经济状况显著不同。

关键数值与推荐

  • 内部一致性 Omega 值 0.729–0.921。
  • 重测信度组内相关系数 >0.7。
  • 缺失数据在 7 个领域处于可接受范围。

临床怎么用

  • PETS-Stroke 可作为卒中试验中的治疗负担结局测量工具,用于评估卒中后治疗负担。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment burden is the workload of health care for people with long-term conditions and the impact on wellbeing. A validated measure of treatment burden for use as an outcome measure in stroke trials is needed. We adapted a patient-reported measure of treatment burden in multimorbidity, Patient Experience With Treatment and Self-Management (PETS), version 2.0, to create a stroke-specific measure, PETS-stroke, and examined its psychometric properties. METHODS: We conducted an observational cohort study. Stroke and transient ischemic attack survivors were recruited between February 2022 to June 2023 from 10 hospitals in the United Kingdom and through the Scottish Health Research Register. Participants completed the PETS-stroke questionnaire along with 3 other patient-reported measures (the Stroke Southampton Self-Management Questionnaire, the Satisfaction With Stroke Care Measure, and the Shortened Stroke Impact Scale). We performed confirmatory factor analysis to test the factor structure of the PETS-stroke. We assessed Spearman rank correlations between PETS-stroke and other patient-reported measures to determine convergent validity. An intraclass correlation coefficient was performed to assess test-retest reliability. Proportions of missing data along with feedback from qualitative interviews were used to determine feasibility. T-tests were conducted to examine variations in PETS-stroke scores based on multimorbidity and socioeconomic factors. RESULTS: Three hundred eighty-one participants were included (mean age, 68.2 [SD, 11.2] years; female, 43.3%). The best fit was achieved with a 9-factor structure, and internal consistency was good (Omega values, 0.729-0.921). The factor loadings for the individual indicator items across 8 of the 9 domains were moderate to strong. All domains of PETS-stroke showed moderate to strong correlations with at least one other patient-reported measure. Test-retest reliability was good for all domains (intraclass correlation coefficient >0.7). Qualitative feedback on feasibility was positive: participants found the questionnaire to be easy and quick to complete, and missing data were within acceptable limits for 7 domains. PETS-stroke scores significantly differed based on multimorbidity in 3 domains and in 8 domains based on socioeconomic status. CONCLUSIONS: Psychometric performance suggests that PETS-stroke is a valid and feasible measure of treatment burden after stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Taylor-Rowan M, Eton DT, McLeod HJ, et al. Validation and Feasibility of PETS-Stroke: A Patient-Reported Measure of Treatment Burden After Stroke. Stroke. 2025. PMID: 40438944. doi:10.1161/STROKEAHA.125.051398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。